14-day Premium Trial Subscription Try For FreeTry Free
$38.20
+0.95 (+2.55%)
At Close: May 02, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $32.03 $45.00 Thursday, 2nd May 2024 CRBP stock ended at $38.20. This is 2.55% more than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 4.03% from a day low at $37.84 to a day high of $39.37.
90 days $20.23 $49.87
52 weeks $3.03 $49.87

Historical Corbus Pharmaceuticals Holdings prices

Date Open High Low Close Volume
Nov 03, 2021 $30.60 $31.80 $30.30 $31.50 24 082
Nov 02, 2021 $31.50 $32.40 $30.00 $31.50 139 809
Nov 01, 2021 $30.30 $31.20 $30.30 $30.90 30 294
Oct 29, 2021 $30.00 $30.60 $30.00 $30.00 22 962
Oct 28, 2021 $30.00 $30.30 $29.70 $30.30 26 023
Oct 27, 2021 $30.30 $30.60 $30.00 $30.00 22 925
Oct 26, 2021 $30.90 $31.02 $30.00 $30.60 26 048
Oct 25, 2021 $29.10 $30.60 $29.01 $30.30 32 488
Oct 22, 2021 $30.90 $30.90 $28.50 $28.53 65 570
Oct 21, 2021 $30.30 $31.20 $30.30 $30.90 18 150
Oct 20, 2021 $31.80 $31.80 $30.30 $30.30 42 971
Oct 19, 2021 $30.30 $32.70 $30.30 $32.10 44 704
Oct 18, 2021 $30.60 $30.90 $30.30 $30.60 19 385
Oct 15, 2021 $30.60 $30.90 $30.30 $30.60 17 725
Oct 14, 2021 $30.90 $31.20 $30.30 $30.60 29 766
Oct 13, 2021 $30.60 $30.90 $30.60 $30.60 8 671
Oct 12, 2021 $30.90 $31.80 $30.60 $30.75 14 728
Oct 11, 2021 $30.60 $31.20 $30.60 $30.90 18 061
Oct 08, 2021 $32.70 $32.70 $30.90 $30.90 22 644
Oct 07, 2021 $30.90 $32.40 $30.60 $32.40 40 159
Oct 06, 2021 $30.30 $30.90 $30.00 $30.30 17 206
Oct 05, 2021 $32.10 $32.70 $30.60 $30.90 33 085
Oct 04, 2021 $30.80 $33.30 $30.00 $32.40 71 706
Oct 01, 2021 $30.90 $31.50 $30.00 $30.60 25 265
Sep 30, 2021 $30.30 $30.60 $30.00 $30.60 23 721
Click to get the best stock tips daily for free!

About Corbus Pharmaceuticals Holdings

Corbus Pharmaceuticals Holdings Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an anti-integrin monoclonal antibody (mAb) for the treatment of cancer and fibrosis that inhibits the act... CRBP Profile

Golden Star

Ticker Date Change Price
BSCQ Apr 30 0.393% $19.09
EQC Apr 30 1.76% $18.72
HRB Apr 30 1.69% $47.23
REG Apr 30 1.35% $59.22
INGR Apr 30 0.576% $114.59
BSJP Apr 29 0.175% $22.91
LYG Apr 29 0.781% $2.56
ORA Apr 29 3.46% $64.48
DHT Apr 24 4.34% $11.28
LPLA Apr 19 2.62% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT